A detailed history of Csenge Advisory Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Csenge Advisory Group holds 3,872 shares of BSX stock, worth $322,808. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,872
Previous 3,594 7.74%
Holding current value
$322,808
Previous $246,000 21.14%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$67.33 - $77.71 $18,717 - $21,603
278 Added 7.74%
3,872 $298,000
Q1 2024

May 03, 2024

BUY
$57.6 - $68.62 $207,014 - $246,620
3,594 New
3,594 $246,000
Q4 2018

Feb 07, 2019

SELL
$31.73 - $39.04 $5,965 - $7,339
-188 Closed
0 $0
Q3 2018

Nov 19, 2018

BUY
$32.83 - $38.63 $6,172 - $7,262
188 New
188 $6,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.